A Study on the Intervention Effect of Therapeutic Horticulture Based on the Healing System on Non-suicidal Self-injury in Adolescent Patients With Depression
Launched by LEI HUANG · Aug 4, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is exploring whether therapeutic gardening can help teenagers with depression who hurt themselves without intending to die (called non-suicidal self-injury). Therapeutic gardening involves activities like planting and caring for plants, which may provide emotional benefits and improve things like mood, sleep, feelings of loneliness, and confidence. The goal is to see if these gardening activities can reduce self-harm and help these young people feel better emotionally.
To join this study, participants need to be diagnosed with moderate to severe depression and have a history of non-suicidal self-injury, based on standard mental health guidelines. Both the teens and their guardians must agree to take part, and the participants should be able to read, write, and communicate normally. People currently at risk of suicide or those who have recently had certain medical treatments (like electroconvulsive therapy) cannot join. If eligible, participants will take part in gardening sessions designed to promote healing and emotional growth. This study has not yet started recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • It meets the diagnostic criteria for moderate to severe depression in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
- • It meets the diagnostic criteria for non-suicidal self-harm in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
- • It meets the diagnostic criteria for non-suicidal self-harm in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
- • The patients and their guardians gave informed consent and voluntarily participated in this study.
- • Have normal reading comprehension ability, language communication ability and writing ability.
- Exclusion Criteria:
- • Have normal reading comprehension ability, language communication ability and writing ability.
- • Have normal reading comprehension ability, language communication ability and writing ability.
- • Those who have received electroconvulsive therapy without convulsions within the past six months or are currently undergoing such treatment.
- • Those who have received electroconvulsive therapy without convulsions within the past six months or are currently undergoing such treatment.
- • Those at risk of suicide and those who commit suicide.
About Lei Huang
Lei Huang is a clinical trial sponsor with expertise in overseeing and managing clinical research studies. Committed to advancing medical knowledge and improving patient outcomes, Lei Huang ensures adherence to regulatory standards and ethical guidelines throughout the research process. With a focus on fostering collaboration among investigators and stakeholders, Lei Huang plays a pivotal role in the successful execution and integrity of clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, , China
Patients applied
Trial Officials
Zhichun Xia
Study Director
The Affiliated Brain Hospital of Guangzhou Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported